SE9903499D0 - Antimicrobial agent for treatment and prophylaxis - Google Patents

Antimicrobial agent for treatment and prophylaxis

Info

Publication number
SE9903499D0
SE9903499D0 SE9903499A SE9903499A SE9903499D0 SE 9903499 D0 SE9903499 D0 SE 9903499D0 SE 9903499 A SE9903499 A SE 9903499A SE 9903499 A SE9903499 A SE 9903499A SE 9903499 D0 SE9903499 D0 SE 9903499D0
Authority
SE
Sweden
Prior art keywords
treatment
positively charged
prophylaxis
infection
antimicrobial agent
Prior art date
Application number
SE9903499A
Other languages
Swedish (sv)
Other versions
SE523243C2 (en
SE9903499L (en
SE523243C3 (en
Inventor
Tomas Bergstroem
Edward Trybala
Marcus Back
Olle Larm
Original Assignee
Medicarb Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicarb Ab filed Critical Medicarb Ab
Priority to SE9903499A priority Critical patent/SE523243C3/en
Publication of SE9903499D0 publication Critical patent/SE9903499D0/en
Priority to AU78205/00A priority patent/AU7820500A/en
Priority to EP00968264A priority patent/EP1225905A1/en
Priority to PCT/SE2000/001864 priority patent/WO2001022973A1/en
Priority to JP2001526183A priority patent/JP2003510283A/en
Publication of SE9903499L publication Critical patent/SE9903499L/en
Publication of SE523243C2 publication Critical patent/SE523243C2/en
Publication of SE523243C3 publication Critical patent/SE523243C3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

The use of a positively charged carbohydrate polymer for the manufacture of a medicament for the prevention of infection by protecting mammalian cells with such positively charged polymer; and a method of treatment of mammalians including man to prevent infection, the treatment being constituted by administering a pharmaceutically effective amount of a positively charged carbohydrate capable of interaction with mammalian cells to protect same against microbial infection.
SE9903499A 1999-09-28 1999-09-28 Antimicrobial preparation for treatment and prophylaxis SE523243C3 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9903499A SE523243C3 (en) 1999-09-28 1999-09-28 Antimicrobial preparation for treatment and prophylaxis
AU78205/00A AU7820500A (en) 1999-09-28 2000-09-26 The use of a positively charged carbohydrate polymer for the prevention of infection
EP00968264A EP1225905A1 (en) 1999-09-28 2000-09-26 The use of a positively charged carbohydrate polymer for the prevention of infection
PCT/SE2000/001864 WO2001022973A1 (en) 1999-09-28 2000-09-26 The use of a positively charged carbohydrate polymer for the prevention of infection
JP2001526183A JP2003510283A (en) 1999-09-28 2000-09-26 Positively charged carbohydrate polymers for infection control

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9903499A SE523243C3 (en) 1999-09-28 1999-09-28 Antimicrobial preparation for treatment and prophylaxis

Publications (4)

Publication Number Publication Date
SE9903499D0 true SE9903499D0 (en) 1999-09-28
SE9903499L SE9903499L (en) 2001-05-11
SE523243C2 SE523243C2 (en) 2004-04-06
SE523243C3 SE523243C3 (en) 2004-05-26

Family

ID=20417177

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9903499A SE523243C3 (en) 1999-09-28 1999-09-28 Antimicrobial preparation for treatment and prophylaxis

Country Status (5)

Country Link
EP (1) EP1225905A1 (en)
JP (1) JP2003510283A (en)
AU (1) AU7820500A (en)
SE (1) SE523243C3 (en)
WO (1) WO2001022973A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119949A1 (en) * 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
WO2003092382A1 (en) * 2002-04-30 2003-11-13 Danish Institute For Fisheries Research Composition and method for controlling microbial adhesion and biofilm formation of surfaces

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0692253A4 (en) * 1992-08-07 1998-06-03 Nippon Soda Co Prophylatic for domestic animal mastitis
SE9402529D0 (en) * 1994-07-19 1994-07-19 Astra Ab Anti-adherents

Also Published As

Publication number Publication date
AU7820500A (en) 2001-04-30
SE523243C2 (en) 2004-04-06
EP1225905A1 (en) 2002-07-31
WO2001022973A1 (en) 2001-04-05
SE9903499L (en) 2001-05-11
JP2003510283A (en) 2003-03-18
SE523243C3 (en) 2004-05-26

Similar Documents

Publication Publication Date Title
MXPA02002895A (en) Topical treatment of streptococcal infections.
EP0668720A4 (en) M-edta pharmaceutical preparations and uses thereof.
AU2931500A (en) Pharmaceutical composition containing nitrate source and an acidifying agent fortreating skin ischaemia
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
BRPI0411016A (en) antiseptic compositions, processes and systems
DK0726768T3 (en) Use of nitric oxide releasing compounds in the manufacture of a medicament for protection in ischemic reperfusion
PT806941E (en) LIPOSOMIC ANTI-BACTERIAL COMPOSITIONS OF LOW RIGIDITY
NO941317D0 (en) System for improved topical delivery of drugs with increased skin penetration
TR199901127T2 (en) Antibacterial 6-O-substituted ketolites.
RS114004A (en) Modified 2' and 3'-nucleoside produgs for treating flaviridae infections
NZ545506A (en) Therapeutic agents useful for treating pain
DE69833377D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAIN LYSOSTAPHIN ALONE OR IN COMBINATION WITH AN ANTIBIOTIC FOR THE TREATMENT OF STAPHYLOKOCKWIN INFECTIONS
CY1107465T1 (en) MELAGATRANI FOR THERAPEUTIC INFECTION
ATE215952T1 (en) HIV PROTEASE INHIBITORS
BR0110382A (en) Use of azalide antibiotic compositions for the treatment or prevention of a bacterial or protozoal infection in mammals
SE9903499D0 (en) Antimicrobial agent for treatment and prophylaxis
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
ES2104223T3 (en) 2 - ((2- (N-ISOBUTYL-N-METHYL) AMINO) -BENCILSULFINIL) BENZMIDAZOLE AS ANTIMICROBIAL AGENT AGAINST HELICOBACTER PYLORI.
AU6432899A (en) Use of metformin to counteract weight gain associated with valproate and other psychotropic medications
HK1036593A1 (en) Use of oxazolidinones in the manufacture of a medicament for treating non-topical infections.
BR0112035A (en) novispirin antimicrobial peptides
BR0308734A (en) Compound, pharmaceutical composition, use of compound, and method for preventing or treating infection
EP1347754A4 (en) Compositions for adhesion prevention
AU2396900A (en) Treatment and prevention of hiv and other viral infections
TR200102019T2 (en) The use of 3-isoxazolidinones and hydroxylamic acids in the treatment of infections.

Legal Events

Date Code Title Description
NUG Patent has lapsed